Back to Browse Journals » OncoTargets and Therapy » Volume 7 » default

OncoTargets and Therapy


Archive: Volume 7, 2014

Induction of multiple drug resistance in HMEC-1 endothelial cells after long-term exposure to sunitinib

Huang LM, Hu CQ, Di Benedetto M, Varin R, Liu JL, Wang L, Vannier JP, Jin J, Janin A, Lu H, Li H

OncoTargets and Therapy 2014, 7:2249-2255

Published Date: 4 December 2014

Angiogenesis and antiangiogenic agents in cervical cancer

Tomao F, Papa A, Rossi L, Zaccarelli E, Caruso D, Zoratto F, Benedetti Panici P, Tomao S

OncoTargets and Therapy 2014, 7:2237-2248

Published Date: 3 December 2014

Microtubule inhibitor-based antibody–drug conjugates for cancer therapy

Klute K, Nackos E, Tasaki S, Nguyen DP, Bander NH, Tagawa ST

OncoTargets and Therapy 2014, 7:2227-2236

Published Date: 3 December 2014

Multidrug resistance protein 1 localization in lipid raft domains and prostasomes in prostate cancer cell lines

Gomà A, Mir R, Martínez-Soler F, Tortosa A, Vidal A, Condom E, Pérez–Tomás R, Giménez-Bonafé P

OncoTargets and Therapy 2014, 7:2215-2225

Published Date: 5 December 2014

Role of urokinase plasminogen activator and plasminogen activator inhibitor mRNA expression as prognostic factors in molecular subtypes of breast cancer

Witzel I, Milde-Langosch K, Schmidt M, Karn T, Becker S, Wirtz R, Rody A, Laakmann E, Schütze D, Jänicke F, Müller V

OncoTargets and Therapy 2014, 7:2205-2213

Published Date: 28 November 2014

EGF and EGFR genetic polymorphisms predict prognosis in locally advanced pharyngolaryngeal squamous cell carcinoma patients receiving postoperative concurrent chemoradiotherapy

Su NW, Leu YS, Lee JC, Liu CJ, Cheng CY, Lin JS, Chen YJ, Chen CK, Fang IC, Hsieh RK, Chang YF

OncoTargets and Therapy 2014, 7:2197-2204

Published Date: 28 November 2014

Doxorubicin-conjugated bacteriophages carrying anti-MHC class I chain-related A for targeted cancer therapy in vitro

Phumyen A, Jantasorn S, Jumnainsong A, Leelayuwat C

OncoTargets and Therapy 2014, 7:2183-2195

Published Date: 28 November 2014

Continuation of bevacizumab and addition of hormone therapy following weekly paclitaxel therapy in HER2-negative metastatic breast cancer

Redondo A, Martínez V, Zamora P, Castelo B, Pinto A, Cruz P, Higuera O, Mendiola M, Hardisson D, Espinosa E

OncoTargets and Therapy 2014, 7:2175-2181

Published Date: 27 November 2014

The association of apoptotic protein expressions sensitive to apoptosis gene, p73 and p53 with the prognosis of cervical carcinoma

Mega Tiber P, Baloglu L, Ozden S, Ozgen Z, Ozyurt H, Eren M, Orun O

OncoTargets and Therapy 2014, 7:2161-2168

Published Date: 26 November 2014

Neoadjuvant chemotherapy in locally advanced cervical carcinoma: which is better, intravenous or intra-arterial?

Gui T, Shen K, Xiang Y, Pan LY, Lang JH, Wu M, Huang HF, Cao DY, Yang JX

OncoTargets and Therapy 2014, 7:2155-2160

Published Date: 26 November 2014

Impact of type 2 diabetes mellitus on the prognosis of early stage triple-negative breast cancer in People’s Republic of China

Ma FJ, Liu ZB, Qu L, Hao S, Liu GY, Wu J, Shao ZM

OncoTargets and Therapy 2014, 7:2147-2154

Published Date: 27 November 2014

Post-nephrectomy foreign-body granuloma in the retroperitoneum mimicking lymph node metastasis of renal cell cancer

Luo J, Mao Y, Cai S, Shen X, Chen S, Xie L

OncoTargets and Therapy 2014, 7:2137-2141

Published Date: 20 November 2014

Long-term complete remission in a patient with intravascular large B-cell lymphoma with central nervous system involvement

Sawada T, Omuro Y, Kobayashi T, Hishima T, Koizumi F, Kanemasa Y, Shimoyama T, Sasaki E, Maeda Y

OncoTargets and Therapy 2014, 7:2133-2136

Published Date: 18 November 2014

Comparison of clinical features, molecular alterations, and prognosis in morphological subgroups of lung invasive mucinous adenocarcinoma

Cai D, Li H, Wang R, Li Y, Pan YJ, Hu HC, Zhang Y, Gong RX, Pan B, Sun YH, Chen HQ

OncoTargets and Therapy 2014, 7:2127-2132

Published Date: 18 November 2014

Large malignant ovarian tumors during pregnancy: two cases

Xu D, Liang C, He J

OncoTargets and Therapy 2014, 7:2121-2125

Published Date: 17 November 2014

Topoisomerase II alpha and TLE3 as predictive markers of response to anthracycline and taxane-containing regimens for neoadjuvant chemotherapy in breast cancer

Susini T, Berti B, Carriero C, Tavella K, Nori J, Vanzi E, Molino C, Di Tommaso M, Santini M, Saladino V, Bianchi S

OncoTargets and Therapy 2014, 7:2111-2120

Published Date: 17 November 2014

Pelvis metastasis from primary choroidal melanoma: a case report

Xiong Y, Lang Y, Tu CQ, Duan H

OncoTargets and Therapy 2014, 7:2107-2110

Published Date: 14 November 2014

Natural history of histologically moderate cervical dysplasia in adolescent and young women

Piris S, Bravo V, Álvarez C, Muñoz-Hernando L, Lorenzo-Hernando E, Oliver R, Marqueta-Marques L, Seoane-Ruiz JM, Tejerizo-Garcia A, Jiménez JS

OncoTargets and Therapy 2014, 7:2101-2106

Published Date: 13 November 2014

Gemcitabine and oxaliplatinum: an effective regimen in patients with refractory and relapsing Hodgkin lymphoma

Gutierrez A, Rodriguez J, Martinez-Serra J, Gines J, Paredes P, Garcia F, Vercher J, Balanzat J, del Campo R, Galan P, Morey M, Sampol A, Novo A, Bento L, García L, Bargay J, Besalduch J

OncoTargets and Therapy 2014, 7:2093-2100

Published Date: 13 November 2014

Elevation of methylated DNA in KILLIN/PTEN in the plasma of patients with thyroid and/or breast cancer

Ng EK, Shin VY, Leung CP, Chan VW, Law FB, Siu MT, Lang BH, Ma ES, Kwong A

OncoTargets and Therapy 2014, 7:2085-2092

Published Date: 11 November 2014

EGFR-TKI therapy for patients with brain metastases from non-small-cell lung cancer: a pooled analysis of published data

Fan Y, Xu X, Xie C

OncoTargets and Therapy 2014, 7:2075-2084

Published Date: 10 November 2014

IL-1α -889 C/T polymorphism and cancer susceptibility: a meta-analysis

Cheng D, Hao Y, Zhou W

OncoTargets and Therapy 2014, 7:2067-2074

Published Date: 10 November 2014

Efficient utilization of EBUS-TBNA samples for both diagnosis and molecular analyses

Oezkan F, Khan AM, Zarogoulidis P, Hohenforst-Schmidt W, Theegarten D, Yasufuku K, Nakajima T, Freitag L, Darwiche K

OncoTargets and Therapy 2014, 7:2061-2065

Published Date: 10 November 2014

Clinical outcome of advanced and metastatic renal cell carcinoma treated with targeted therapy: is there a difference between young and old patients?

Zhang G, Zhu Y, Dong D, Gu W, Zhang H, Sun L, Ye D

OncoTargets and Therapy 2014, 7:2043-2052

Published Date: 3 November 2014

Antisense therapeutics in oncology: current status

Farooqi AA, Rehman ZU, Muntane J

OncoTargets and Therapy 2014, 7:2035-2042

Published Date: 3 November 2014

Proapoptotic and antiinvasive activity of Rac1 small molecule inhibitors on malignant glioma cells

Cardama GA, Gonzalez N, Ciarlantini M, Gandolfi Donadío L, Comin MJ, Alonso DF, Menna PL, Gomez DE

OncoTargets and Therapy 2014, 7:2021-2033

Published Date: 30 October 2014

The effects of ponatinib, a multi-targeted tyrosine kinase inhibitor, against human U87 malignant glioblastoma cells

Zhang J, Zhou Q, Gao G, Wang Y, Fang Z, Li G, Yu M, Kong L, Xing Y, Gao X

OncoTargets and Therapy 2014, 7:2013-2019

Published Date: 30 October 2014

Gli3 silencing enhances cyclopamine suppressive effects on ovarian cancer

Liu HY, Dong Z

OncoTargets and Therapy 2014, 7:2007-2011

Published Date: 30 October 2014

Ramucirumab: preclinical research and clinical development

Aprile G, Rijavec E, Fontanella C, Rihawi K, Grossi F

OncoTargets and Therapy 2014, 7:1997-2006

Published Date: 29 October 2014

Prognostic significance of CDH13 hypermethylation and mRNA in NSCLC

Xue R, Yang C, Zhao F, Li D

OncoTargets and Therapy 2014, 7:1987-1996

Published Date: 31 October 2014

B7-H3 expression in breast cancer and upregulation of VEGF through gene silence

Sun J, Guo YD, Li XN, Zhang YQ, Gu L, Wu PP, Bai GH, Xiao Y

OncoTargets and Therapy 2014, 7:1979-1986

Published Date: 29 October 2014

Profile of belinostat for the treatment of relapsed or refractory peripheral T-cell lymphoma

Bodiford A, Bodge M, Talbott MS, Reddy NM

OncoTargets and Therapy 2014, 7:1971-1977

Published Date: 24 October 2014

Downregulated Ku70 and ATM associated to poor prognosis in colorectal cancer among Chinese patients

Lu YF, Gao JY, Lu YM

OncoTargets and Therapy 2014, 7:1955-1961

Published Date: 24 October 2014

Targeting the epithelial to mesenchymal transition in glioblastoma: the emerging role of MET signaling

Lee JK, Joo KM, Lee J, Yoon Y, Nam DH

OncoTargets and Therapy 2014, 7:1933-1944

Published Date: 20 October 2014

Angiopoietin 2 as a therapeutic target in hepatocellular carcinoma treatment: current perspectives

Bupathi M, Kaseb A, Janku F

OncoTargets and Therapy 2014, 7:1927-1932

Published Date: 20 October 2014

Metronomic capecitabine in gastroenteropancreatic neuroendrocrine tumors: a suitable regimen and review of the literature

Bongiovanni A, Riva N, Calpona S, Ricci M, Gunelli E, Liverani C, La Manna F, De Vita A, Monti M, Severi S, Pieri F, Amadori E, Galassi R, Cavaliere D, Zaccaroni A, Tartaglia A, Lunedei V, Gardini A, Mercatali L, Amadori D, Ibrahim T

OncoTargets and Therapy 2014, 7:1919-1926

Published Date: 20 October 2014

More than 9 years of continuous trastuzumab treatment in metastatic breast cancer without cardiac toxicity: a case report and literature review

Badulescu F, Badulescu A, Paul D, Popescu CF, Florescu C

OncoTargets and Therapy 2014, 7:1911-1917

Published Date: 17 October 2014

Clinical utility of recombinant adenoviral human p53 gene therapy: current perspectives

Chen GX, Zhang S, He XH, Liu SY, Ma C, Zou XP

OncoTargets and Therapy 2014, 7:1901-1909

Published Date: 21 October 2014

A survival analysis comparing women with ovarian low-grade serous carcinoma to those with high-grade histology

Chen M, Jin Y, Bi YL, Yin J, Wang YX, Pan LY

OncoTargets and Therapy 2014, 7:1891-1899

Published Date: 16 October 2014

Inhibition of Mus81 by siRNA enhances sensitivity to 5-FU in breast carcinoma cell lines

Qian Y, Liu YN, Yan QY, Lv J, Ni XY, Wu YL, Dong XJ

OncoTargets and Therapy 2014, 7:1883-1890

Published Date: 21 October 2014

Analysis of exfoliated gastric carcinoma cells attached on surgical supplies

Yu XF, Ma YY, Hu XQ, Zhang QF, Ye ZY

OncoTargets and Therapy 2014, 7:1869-1873

Published Date: 10 October 2014

Risk of treatment-related deaths with vascular endothelial growth factor receptor tyrosine kinase inhibitors: a meta-analysis of 41 randomized controlled trials

Hong SD, Fang WF, Liang WH, Yan Y, Zhou T, Qin T, Wu X, Ma YX, Zhao YY, Yang YP, Hu ZH, Xue C, Hou X, Chen Y, Huang Y, Zhao HY, Zhang L

OncoTargets and Therapy 2014, 7:1851-1867

Published Date: 7 October 2014

Obstructive jaundice caused by intraductal metastasis of lung adenocarcinoma

Ochi N, Goto D, Yamane H, Yamagishi T, Honda Y, Monobe Y, Kawamoto H, Takigawa N

OncoTargets and Therapy 2014, 7:1847-1850

Published Date: 7 October 2014

Profile of trebananib (AMG386) and its potential in the treatment of ovarian cancer

Liontos M, Lykka M, Dimopoulos MA, Bamias A

OncoTargets and Therapy 2014, 7:1837-1845

Published Date: 4 October 2014

Colorectal cancer in Chinese patients: current and emerging treatment options

Li L, Ma BBY

OncoTargets and Therapy 2014, 7:1817-1828

Published Date: 4 October 2014

A new inflammation index is useful for patients with esophageal squamous cell carcinoma

Feng JF, Huang Y, Chen QX

OncoTargets and Therapy 2014, 7:1811-1815

Published Date: 30 September 2014

Study of the mechanism of sonodynamic therapy in a rat glioma model

Song D, Yue W, Li Z, Li J, Zhao J, Zhang N

OncoTargets and Therapy 2014, 7:1801-1810

Published Date: 30 September 2014

An evidence-based review of ixazomib citrate and its potential in the treatment of newly diagnosed multiple myeloma

Offidani M, Corvatta L, Caraffa P, Gentili S, Maracci L, Leoni P

OncoTargets and Therapy 2014, 7:1793-1800

Published Date: 29 September 2014

Capecitabine-induced cardiotoxicity: more evidence or clinical approaches to protect the patients' heart?

Fontanella C, Aita M, Cinausero M, Aprile G, Baldin MG, Dusi V, Lestuzzi C, Fasola G, Puglisi F

OncoTargets and Therapy 2014, 7:1783-1791

Published Date: 29 September 2014

The expression sequence tag is an effective method for screening DNA segments that predict urinary bladder transitional cell carcinoma prognosis

Yang PS, Hsu YC, Lin YH, Hou CP, Chen CL, Chang PL, Juang HH, Tsui KH

OncoTargets and Therapy 2014, 7:1777-1781

Published Date: 30 September 2014

Crenolanib, a PDGFR inhibitor, suppresses lung cancer cell proliferation and inhibits tumor growth in vivo

Wang P, Song L, Ge H, Jin P, Jiang Y, Hu W, Geng N

OncoTargets and Therapy 2014, 7:1761-1768

Published Date: 26 September 2014

Expression of YY1 correlates with progression and metastasis in esophageal squamous cell carcinomas

Luo J, Jiang X, Cao L, Dai K, Zhang S, Ge X, Zhou X, Lu X

OncoTargets and Therapy 2014, 7:1753-1759

Published Date: 26 September 2014

Prognostic value of preoperative inflammatory markers in Chinese patients with breast cancer

Yao MY, Liu Y, Jin HL, Liu XJ, Lv KZ, Wei HY, Du CY, Wang SQ, Wei BJ, Fu PF

OncoTargets and Therapy 2014, 7:1743-1752

Published Date: 26 September 2014

Overexpression of ETV4 protein in triple-negative breast cancer is associated with a higher risk of distant metastasis

Yuan ZY, Dai T, Wang SS, Peng RJ, Li XH, Qin T, Song LB, Wang X

OncoTargets and Therapy 2014, 7:1733-1742

Published Date: 26 September 2014

PTK7 as a potential prognostic and predictive marker of response to adjuvant chemotherapy in breast cancer patients, and resistance to anthracycline drugs

Ataseven B, Gunesch A, Eiermann W, Kates RE, Högel B, Knyazev P, Ullrich A, Harbeck N

OncoTargets and Therapy 2014, 7:1723-1731

Published Date: 6 October 2014

Brentuximab vedotin for relapsed or refractory CD30+ Hodgkin lymphoma: a multicenter analysis from Asia

Yang QM, Hong JY, Ko YH, Lin SY, Au WY, Choi MK, Park S, Kim SJ, Kim WS

OncoTargets and Therapy 2014, 7:1717-1722

Published Date: 26 September 2014

Tumor heterogeneity in the recurrence of epithelial ovarian cancer demonstrated by polycomb group proteins

Gui T, Bai HM, Zeng JF, Zhong ZJ, Cao DY, Cui QC, Chen J, Yang JX, Shen K

OncoTargets and Therapy 2014, 7:1705-1716

Published Date: 25 September 2014

The emerging role of class-3 semaphorins and their neuropilin receptors in oncology

Nasarre P, Gemmill RM, Drabkin HA

OncoTargets and Therapy 2014, 7:1663-1687

Published Date: 24 September 2014

Clinical significance of UGT1A1 gene polymorphisms on irinotecan-based regimens as the treatment in metastatic colorectal cancer

Li MM, Wang ZH, Guo J, Liu J, Li CZ, Liu L, Shi H, Liu LY, Li HH, Xie C, Zhang X, Sun WW, Fang S, Bi X

OncoTargets and Therapy 2014, 7:1653-1661

Published Date: 23 September 2014

The target therapy of ovarian clear cell carcinoma

Jin Y, Li Y, Pan LY

OncoTargets and Therapy 2014, 7:1647-1652

Published Date: 23 September 2014

Cyclophosphamide-induced symptomatic hyponatremia, a rare but severe side effect: a case report

Elazzazy S, Mohamed AE, Gulied A

OncoTargets and Therapy 2014, 7:1641-1645

Published Date: 30 September 2014

Profile of selumetinib and its potential in the treatment of melanoma

Kim DW, Patel SP

OncoTargets and Therapy 2014, 7:1631-1639

Published Date: 19 September 2014

Expression and clinical significance of the long non-coding RNA PVT1 in human gastric cancer

Ding J, Li D, Gong M, Wang J, Huang X, Wu T, Wang C

OncoTargets and Therapy 2014, 7:1625-1630

Published Date: 18 September 2014

Nanotetrac targets integrin αvβ3 on tumor cells to disorder cell defense pathways and block angiogenesis

Davis PJ, Lin HY, Sudha T, Yalcin M, Tang HY, Hercbergs A, Leith JT, Luidens MK, Ashur-Fabian O, Incerpi S, Mousa SA

OncoTargets and Therapy 2014, 7:1619-1624

Published Date: 18 September 2014

Isolation, detection, and immunomorphological characterization of circulating tumor cells (CTCs) from patients with different types of sarcoma using isolation by size of tumor cells: a window on sarcoma-cell invasion

Chinen LTD, Mello CAL, Abdallah EA, Ocea LMM, Buim ME, Breve NM, Gasparini Junior JL, Fanelli MF, Paterlini-Bréchot P

OncoTargets and Therapy 2014, 7:1609-1617

Published Date: 16 September 2014

Arsenic trioxide-based therapy in relapsed/refractory multiple myeloma patients: a meta-analysis and systematic review

He XP, Yang K, Chen P, Liu B, Zhang Y, Wang F, Guo Z, Liu XD, Lou JX, Chen HR

OncoTargets and Therapy 2014, 7:1593-1599

Published Date: 10 September 2014

MiR-206 functions as a tumor suppressor and directly targets K-Ras in human oral squamous cell carcinoma

Lin FO, Yao LJ, Xiao J, Liu DF, Ni ZY

OncoTargets and Therapy 2014, 7:1583-1591

Published Date: 11 September 2014

Antiangiogenic cancer drug sunitinib exhibits unexpected proangiogenic effects on endothelial cells

Norton KA, Han ZY, Popel AS, Pandey NB

OncoTargets and Therapy 2014, 7:1571-1582

Published Date: 9 September 2014

HIF1α is an independent prognostic factor for overall survival in advanced primary epithelial ovarian cancer – a study of the OVCAD Consortium

Braicu EI, Luketina H, Richter R, Cacsire Castillo-Tong D, Lambrechts S, Mahner S, Concin N, Mentze M, Zeillinger R, Vergote I, Sehouli J

OncoTargets and Therapy 2014, 7:1563-1569

Published Date: 11 September 2014

Bevacizumab in Japanese patients with malignant glioma: from basic research to clinical trial

Takano S, Ishikawa E, Nakai K, Matsuda M, Masumoto T, Yamamoto T, Matsumura A

OncoTargets and Therapy 2014, 7:1551-1562

Published Date: 5 September 2014

Bupivacaine administered intrathecally versus rectally in the management of intractable rectal cancer pain in palliative care

Zaporowska-Stachowiak I, Kowalski G, Łuczak J, Kosicka K, Kotlinska-Lemieszek A, Sopata M, Główka F

OncoTargets and Therapy 2014, 7:1541-1550

Published Date: 6 October 2014

An individual drug-therapy and genetic testing report of temporal bone verrucous carcinoma

Tan HL, Liu Y, Zhu GC, Pi LM, Huang DH, Zhang X

OncoTargets and Therapy 2014, 7:1535-1540

Published Date: 4 September 2014

ER-α36: a novel biomarker and potential therapeutic target in breast cancer

Su XY, Xu X, Li GL, Lin BY, Cao J, Teng LS

OncoTargets and Therapy 2014, 7:1525-1533

Published Date: 30 August 2014

Long-term outcomes from dose-escalated image-guided intensity-modulated radiotherapy with androgen deprivation: encouraging results for intermediate- and high-risk prostate cancer

Wilcox SW, Aherne NJ, Benjamin LC, Wu B, de Campos Silva T, McLachlan CS, McKay MJ, Last AJ, Shakespeare TP

OncoTargets and Therapy 2014, 7:1519-1523

Published Date: 30 August 2014

Cytoprotection “gone astray’’: Nrf2 and its role in cancer

Geismann C, Arlt A, Sebens S, Schäfer H

OncoTargets and Therapy 2014, 7:1497-1518

Published Date: 26 August 2014

The involvement of Kras gene 3'-UTR polymorphisms in risk of cancer and influence on patient response to anti-EGFR therapy in metastatic colorectal cancer: a meta-analysis

Ying HQ, Wang F, He BS, Pan YQ, Gao TY, Xu YQ, Li R, Deng QW, Sun HL, Wang SK

OncoTargets and Therapy 2014, 7:1487-1496

Published Date: 25 August 2014

miR-129 as a novel therapeutic target and biomarker in gastrointestinal cancer

Fesler A, Zhai H, Ju J

OncoTargets and Therapy 2014, 7:1481-1485

Published Date: 21 August 2014

High infiltration of tumor-associated macrophages in triple-negative breast cancer is associated with a higher risk of distant metastasis

Yuan ZY, Luo RZ, Peng RJ, Wang SS, Xue C

OncoTargets and Therapy 2014, 7:1475-1480

Published Date: 21 August 2014

Bevacizumab in combination with chemotherapy in platinum-sensitive ovarian cancer [Corrigendum]

Della Pepa C, Banerjee S

OncoTargets and Therapy 2014, 7:1473-1474

Published Date: 20 August 2014

The coexpression and clinical significance of costimulatory molecules B7-H1, B7-H3, and B7-H4 in human pancreatic cancer

Chen Y, Sun J, Zhao H, Zhu DM, Zhi QM, Song SD, Zhang LF, He SB, Kuang YT, Zhang ZX, Li DC

OncoTargets and Therapy 2014, 7:1465-1472

Published Date: 19 August 2014

A simple in vitro method for evaluating dendritic cell-based vaccinations

Pham PV, Nguyen NT, Nguyen HM, Khuat LT, Le PM, Pham VQ, Nguyen ST, Phan NK

OncoTargets and Therapy 2014, 7:1455-1464

Published Date: 18 August 2014

Glucagonoma syndrome: a case report with focus on skin disorders

Fang S, Li S, Cai T

OncoTargets and Therapy 2014, 7:1449-1453

Published Date: 14 August 2014

Isothermal multiple displacement amplification: a methodical approach enhancing molecular routine diagnostics of microcarcinomas and small biopsies

Mairinger FD, Walter RFH, Vollbrecht C, Hager T, Worm K, Ting S, Wohlschläger J, Zarogoulidis P, Zarogoulidis K, Schmid KW

OncoTargets and Therapy 2014, 7:1441-1447

Published Date: 13 August 2014

Sam68 is a novel marker for aggressive neuroblastoma [Corrigendum]

Zhao XH, Li ZQ, He BF, Liu JC, Li SS, Zhou L, Pan CL, Yu Z, Xu Z

OncoTargets and Therapy 2014, 7:1439-1440

Published Date: 14 August 2014

Oncogenic mutations are associated with histological subtypes but do not have an independent prognostic value in lung adenocarcinoma

Hu H, Pan Y, Li Y, Wang L, Wang R, Zhang Y, Li H, Ye T, Zhang Y, Luo X, Shao L, Sun Z, Cai D, Xu J, Lu Q, Deng Y, Shen L, Ji H, Sun Y, Chen H

OncoTargets and Therapy 2014, 7:1423-1437

Published Date: 13 August 2014

Initial LDH level can predict the survival benefit from bevacizumab in the first-line setting in Chinese patients with metastatic colorectal cancer

Yin CX, Jiang C, Liao FX, Rong YM, Cai XY, Guo GF, Qiu HJ, Chen XX, Zhang B, He WZ, Xia LP

OncoTargets and Therapy 2014, 7:1415-1422

Published Date: 11 August 2014

Outcomes analysis of an alternative formulation of PEGylated liposomal doxorubicin in recurrent epithelial ovarian carcinoma during the drug shortage era

Berger JL, Smith A, Zorn KK, Sukumvanich P, Olawaiye AB, Kelley J, Krivak TC

OncoTargets and Therapy 2014, 7:1409-1413

Published Date: 8 August 2014

PKN1 modulates TGFß and EGF signaling in HEC-1-A endometrial cancer cell line

Attarha S, Saini RK, Andersson S, Mints M, Souchelnytskyi S

OncoTargets and Therapy 2014, 7:1397-1408

Published Date: 4 August 2014

Silencing B7-H1 enhances the anti-tumor effect of bladder cancer antigen-loaded dendritic cell vaccine in vitro

Wang S, Wang YH, Liu J, Shao SX, Li XJ, Gao JN, Niu HT, Wang XS

OncoTargets and Therapy 2014, 7:1389-1396

Published Date: 5 August 2014

Paclitaxel- and/or cisplatin-induced ocular neurotoxicity: a case report and literature review

Li Y, Li YP, Li JY, Pi GL, Tan WY

OncoTargets and Therapy 2014, 7:1361-1366

Published Date: 31 July 2014

PD-1 as an emerging therapeutic target in renal cell carcinoma: current evidence

Tykodi SS

OncoTargets and Therapy 2014, 7:1349-1359

Published Date: 25 July 2014

Comparison of short-term effect of thoracoscopic segmentectomy and thoracoscopic lobectomy for the solitary pulmonary nodule and early-stage lung cancer

Ren MM, Meng QJ, Zhou WY, Kong FY, Yang B, Yuan J, Wu DW, Zhang J, Li QQ, Lin YS, Viswanathan VB, Song X

OncoTargets and Therapy 2014, 7:1343-1347

Published Date: 24 July 2014

External iliac vein – transplant ureteral fistula combined with renal cell carcinoma: an unusual case of hematuria

Luo JD, Liu B, Wang P, Zhou F, Xu XL, Li SQ, Cai SL, Wang YM

OncoTargets and Therapy 2014, 7:1339-1342

Published Date: 23 July 2014

MicroRNAs transported by exosomes in body fluids as mediators of intercellular communication in cancer

Salido-Guadarrama I, Romero-Cordoba S, Peralta-Zaragoza O, Hidalgo-Miranda A, Rodríguez-Dorantes M

OncoTargets and Therapy 2014, 7:1327-1338

Published Date: 21 July 2014

High expression of HEF1 is associated with poor prognosis in urinary bladder carcinoma

Zhang Q, Wang HJ, Zhang DH, Ru GQ, He XJ, Ma YY

OncoTargets and Therapy 2014, 7:1319-1326

Published Date: 21 July 2014

Circulating tumor cells in the central and peripheral venous compartment – assessing hematogenous dissemination after transarterial chemoembolization of hepatocellular carcinoma

Fang ZT, Zhang W, Wang GZ, Zhou B, Yang GW, Qu XD, Liu R, Qian S, Zhu L, Liu LX, Wang JH

OncoTargets and Therapy 2014, 7:1311-1318

Published Date: 18 July 2014

Prognostic significance of thymidylate synthase in postoperative non-small cell lung cancer patients

Zhao HY, Ma GW, Zou BY, Li M, Lin SX, Zhao LP, Guo Y, Huang Y, Tian Y, Xie D, Zhang L

OncoTargets and Therapy 2014, 7:1301-1310

Published Date: 16 July 2014

Sorafenib in radioactive iodine-refractory well-differentiated metastatic thyroid cancer

McFarland DC, Misiukiewicz KJ

OncoTargets and Therapy 2014, 7:1291-1299

Published Date: 15 July 2014

Salivary expression of soluble HER2 in breast cancer patients with positive and negative HER2 status

Laidi F, Bouziane A, Lakhdar A, Khabouze S, Rhrab B, Zaoui F

OncoTargets and Therapy 2014, 7:1285-1289

Published Date: 14 July 2014

Clinical utility of trabectedin for the treatment of ovarian cancer: current evidence

Mascilini F, Amadio G, Di Stefano MG, Ludovisi M, Di Legge A, Conte C, De Vincenzo R, Ricci C, Masciullo V, Salutari V, Scambia G, Ferrandina G

OncoTargets and Therapy 2014, 7:1273-1284

Published Date: 12 July 2014

Discordance rate of HER2 status in primary breast carcinomas versus synchronous axillary lymph node metastases: a multicenter retrospective investigation

Ieni A, Barresi V, Caltabiano R, Cascone AM, Del Sordo R, Cabibi D, Zeppa P, Lanzafame S, Sidoni A, Franco V, Tuccari G

OncoTargets and Therapy 2014, 7:1267-1272

Published Date: 11 July 2014

Randomized double-blind trial of prophylactic topical Evozac® Calming Skin Spray for gefitinib-associated acne-like eruption

Wang Y, Yang Y, Xu J, Yu J, Liu X, Gao R, Zhang L

OncoTargets and Therapy 2014, 7:1261-1266

Published Date: 10 July 2014

Lack of association between the XPD Lys751Gln polymorphism and colorectal cancer risk: a meta-analysis

Zhang T, Zhang DM, Zhao D, Hou XM, Ma SC, Liu XJ

OncoTargets and Therapy 2014, 7:1255-1260

Published Date: 12 July 2014

Clinical significance and association of RUNX3 hypermethylation frequency with colorectal cancer: a meta-analysis

Mu WP, Wang J, Niu Q, Shi N, Lian HF

OncoTargets and Therapy 2014, 7:1237-1245

Published Date: 10 July 2014

Targeted drug delivery via folate receptors in recurrent ovarian cancer: a review

Marchetti C, Palaia I, Giorgini M, De Medici C, Iadarola R, Vertechy L, Domenici L, Di Donato V, Tomao F, Muzii L, Benedetti Panici P

OncoTargets and Therapy 2014, 7:1223-1236

Published Date: 10 July 2014

CP-673451, a platelet-derived growth-factor receptor inhibitor, suppresses lung cancer cell proliferation and migration

Xi YL, Chen M, Liu XM, Lu ZM, Ding Y, Li DT

OncoTargets and Therapy 2014, 7:1215-1221

Published Date: 3 July 2014

Histological type-specific prognostic factors of cervical small cell neuroendocrine carcinoma, adenocarcinoma, and squamous cell carcinoma

Intaraphet S, Kasatpibal N, Søgaard M, Khunamornpong S, Patumanond J, Chandacham A, Chitapanarux I, Siriaunkgul S

OncoTargets and Therapy 2014, 7:1205-1214

Published Date: 1 July 2014

Expression profiles and initial confirmation of long noncoding RNAs in Chinese patients with pulmonary adenocarcinoma

Zhao X, Zhu W, Zha W, Chen F, Wu Z, Liu Y, Huang M

OncoTargets and Therapy 2014, 7:1195-1204

Published Date: 1 July 2014

Correlation between EGFR mutation status and response to first-line platinum-based chemotherapy in patients with advanced non-small cell lung cancer

Fang S, Wang ZH, Guo J, Liu J, Li CZ, Liu L, Shi H, Liu LY, Li HH, Xie C, Zhang X, Sun WW, Li MM

OncoTargets and Therapy 2014, 7:1185-1193

Published Date: 1 July 2014

A single-institution experience with bevacizumab in the treatment of metastatic colorectal cancer and in conjunction with liver resection

Osterlund P, Peltonen R, Alanko T, Bono P, Isoniemi H

OncoTargets and Therapy 2014, 7:1177-1184

Published Date: 1 July 2014

Modeling pegylated liposomal doxorubicin-induced hand-foot syndrome and intestinal mucositis in zebrafish

Chen YH, Lee YT, Wen CC, Chen YC, Chen YJ

OncoTargets and Therapy 2014, 7:1169-1175

Published Date: 1 July 2014

Clinicopathological and biological significance of aberrant activation of glycogen synthase kinase-3 in ovarian cancer

Fu Y, Wang X, Cheng X, Ye F, Xie X, Lu W

OncoTargets and Therapy 2014, 7:1159-1168

Published Date: 25 June 2014

Mapping lymph nodes in cancer management – role of 99mTc-tilmanocept injection

Tausch C, Baege A, Rageth C

OncoTargets and Therapy 2014, 7:1151-1158

Published Date: 24 June 2014

Integration of multidisciplinary technologies for real time target visualization and verification for radiotherapy

Chang WC, Chen CS, Tai HC, Liu CY, Chen YJ

OncoTargets and Therapy 2014, 7:1143-1150

Published Date: 23 June 2014

Clinical analysis of 13 males with primary choriocarcinoma and review of the literature

Jiang F, Xiang Y, Feng FZ, Ren T, Cui ZM, Wan XR

OncoTargets and Therapy 2014, 7:1135-1141

Published Date: 20 June 2014

Stemness and plasticity of lung cancer cells: paving the road for better therapy

Luo JD, Zhou XF, Yakisich JS

OncoTargets and Therapy 2014, 7:1129-1134

Published Date: 23 June 2014

Combination therapy with brentuximab vedotin and cisplatin/cytarabine in a patient with primarily refractory anaplastic lymphoma kinase positive anaplastic large cell lymphoma

Heidegger S, Beer AJ, Geissinger E, Rosenwald A, Peschel C, Ringshausen I, Keller U

OncoTargets and Therapy 2014, 7:1123-1127

Published Date: 20 June 2014

Neoadjuvant therapy for locally advanced melanoma: new strategies with targeted therapies

La Greca M, Grasso G, Antonelli G, Russo AE, Bartolotta S, D’Angelo A, Vitale FV, Ferraù F

OncoTargets and Therapy 2014, 7:1115-1121

Published Date: 19 June 2014

Recall radiation dermatitis by sorafenib following stereotactic body radiation therapy

Hsieh CH, Lin SC, Shueng PW, Kuo DY

OncoTargets and Therapy 2014, 7:1111-1114

Published Date: 18 June 2014

Progression-free survival as a potential surrogate for overall survival in metastatic breast cancer

Beauchemin C, Cooper D, Lapierre ME, Yelle L, Lachaine J

OncoTargets and Therapy 2014, 7:1101-1110

Published Date: 18 June 2014

Potential role of daratumumab in the treatment of multiple myeloma

Khagi Y, Mark TM

OncoTargets and Therapy 2014, 7:1095-1100

Published Date: 18 June 2014

ID2 predicts poor prognosis in breast cancer, especially in triple-negative breast cancer, and inhibits E-cadherin expression

Li K, Yao L, Chen L, Cao ZG, Yu SJ, Kuang XY, Hu X, Shao ZM

OncoTargets and Therapy 2014, 7:1083-1094

Published Date: 18 June 2014

Pilot study of intratumoral injection of recombinant heat shock protein 70 in the treatment of malignant brain tumors in children

Shevtsov MA, Kim AV, Samochernych KA, Romanova IV, Margulis BA, Guzhova IV, Yakovenko IV, Ischenko AM, Khachatryan WA

OncoTargets and Therapy 2014, 7:1071-1081

Published Date: 18 June 2014

HCA519/TPX2: a potential T-cell tumor-associated antigen for human hepatocellular carcinoma

Aref AM, Hoa NT, Ge L, Agrawal A, Dacosta-Iyer M, Lambrecht N, Ouyang Y, Cornforth AN, Jadus MR

OncoTargets and Therapy 2014, 7:1061-1070

Published Date: 13 June 2014

Nimotuzumab plus chemotherapy versus chemotherapy alone in advanced non-small-cell lung cancer: a multicenter, randomized, open-label Phase II study

Babu KG, Prabhash K, Vaid AK, Sirohi B, Diwakar RB, Rao R, Kar M, Malhotra H, Nag S, Goswami C, Raina V, Mohan R

OncoTargets and Therapy 2014, 7:1051-1060

Published Date: 13 June 2014

Myelodysplastic disorders carrying both isolated del(5q) and JAK2V617F mutation: concise review, with focus on lenalidomide therapy

Musto P, Simeon V, Guariglia R, Bianchino G, Grieco V, Nozza F, La Rocca F, Marziano G, Lalinga AV, Fabiani E, Voso MT, Scaravaglio P, Mecucci C, D'Arena G

OncoTargets and Therapy 2014, 7:1043-1050

Published Date: 13 June 2014

Bevacizumab in combination with chemotherapy in platinum-sensitive ovarian cancer

Della Pepa C, Banerjee S

OncoTargets and Therapy 2014, 7:1025-1032

Published Date: 19 June 2014

Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis

Vyas D, Laput G, Vyas AK

OncoTargets and Therapy 2014, 7:1015-1023

Published Date: 12 June 2014

Emerging molecular targets in oncology: clinical potential of MET/hepatocyte growth-factor inhibitors

Smyth EC, Sclafani F, Cunningham D

OncoTargets and Therapy 2014, 7:1001-1014

Published Date: 12 June 2014

xCELLigence system for real-time label-free monitoring of growth and viability of cell lines from hematological malignancies

Martinez-Serra J, Gutierrez A, Muñoz-Capó S, Navarro-Palou M, Ros T, Amat JC, Lopez B, Marcus TF, Fueyo L, Suquia AG, Gines J, Rubio F, Ramos R, Besalduch J

OncoTargets and Therapy 2014, 7:985-994

Published Date: 12 June 2014

The potential roles of hepatocyte growth factor (HGF)-MET pathway inhibitors in cancer treatment

Parikh RA, Wang P, Beumer JH, Chu E, Appleman LJ

OncoTargets and Therapy 2014, 7:969-983

Published Date: 11 June 2014

Paraganglioma of the vagina: a case report and review of the literature

Cai T, Li YC, Jiang QM, Wang D, Huang Y

OncoTargets and Therapy 2014, 7:965-968

Published Date: 10 June 2014

Prognosis of patients with hepatocellular carcinoma and hypersplenism after surgery: a single-center experience from the People's Republic of China

Li C, Zhao H, Zhao J, Li Z, Huang Z, Zhang Y, Bi X, Cai J

OncoTargets and Therapy 2014, 7:957-964

Published Date: 9 June 2014

Critical appraisal of pemetrexed in the treatment of NSCLC and metastatic pulmonary nodules

Li X, Wei S, Chen J

OncoTargets and Therapy 2014, 7:937-945

Published Date: 6 June 2014

Stereotactic body radiation therapy using the CyberKnife® system for patients with liver metastases

Yuan ZY, Meng MB, Liu CL, Wang HH, Jiang C, Song YC, Zhuang HQ, Yang D, Wang JS, Wei W, Li FT, Zhao LJ, Wang P

OncoTargets and Therapy 2014, 7:915-923

Published Date: 12 June 2014

Effect of NQO1 C609T polymorphism on prostate cancer risk: a meta-analysis

Zhang Q, Zheng M, Qi XL, Liu F, Mao ZJ, Zhang DH

OncoTargets and Therapy 2014, 7:907-914

Published Date: 5 June 2014

The potential clinical applications and prospects of microRNAs in lung cancer

Gao Y, Gao F, Ma JL, Sun WZ, Song LP

OncoTargets and Therapy 2014, 7:901-906

Published Date: 4 June 2014

miR-544a promotes the invasion of lung cancer cells by targeting cadherina 1 in vitro

Mo X, Zhang F, Liang H, Liu M, Li H, Xia H

OncoTargets and Therapy 2014, 7:895-900

Published Date: 4 June 2014

High expression of 23 kDa protein of augmenter of liver regeneration (ALR) in human hepatocellular carcinoma

Yu HY, Zhu MH, Xiang DR, Li J, Sheng JF

OncoTargets and Therapy 2014, 7:887-893

Published Date: 2 June 2014

Clinical significance of promoter region hypermethylation of microRNA-148a in gastrointestinal cancers

Sun JX, Song YX, Wang ZN, Wang GL, Gao P, Chen XW, Gao ZH, Xu HM

OncoTargets and Therapy 2014, 7:853-863

Published Date: 28 May 2014

Critical appraisal of the role of gefitinib in the management of locally advanced or metastatic non-small cell lung cancer

Yuan Y, Li XF, Chen JQ, Dong CX, Weng SS, Huang JJ

OncoTargets and Therapy 2014, 7:841-852

Published Date: 28 May 2014

Cerium oxide nanoparticles in cancer

Gao Y, Chen K, Ma JL, Gao F

OncoTargets and Therapy 2014, 7:835-840

Published Date: 27 May 2014

Comprehensive clinical and pathological analysis of aggressive renal epithelioid angiomyolipoma: report of three cases

Luo J, Liu B, Wang Y, Li J, Wang P, Chen J, Wang C

OncoTargets and Therapy 2014, 7:823-827

Published Date: 27 May 2014

Prevalence and relationship between major depressive disorder and lung cancer: a cross-sectional study

Maneeton B, Maneeton N, Reungyos J, Intaprasert S, Leelarphat S, Thongprasert S

OncoTargets and Therapy 2014, 7:815-821

Published Date: 27 May 2014

Prior EGFR tyrosine-kinase inhibitor therapy did not influence the efficacy of subsequent pemetrexed plus platinum in advanced chemonaïve patients with EGFR-mutant lung adenocarcinoma

Tseng JS, Yang TY, Chen KC, Hsu KH, Yu CJ, Liao WY, Tsai CR, Tsai MH, Yu SL, Su KY, Chen JJ, Chen HY, Chang GC

OncoTargets and Therapy 2014, 7:799-805

Published Date: 23 May 2014

Positron emission tomographic monitoring of dual phosphatidylinositol-3-kinase and mTOR inhibition in anaplastic large cell lymphoma

Graf N, Li ZL, Herrmann K, Weh D, Aichler M, Slawska J, Walch A, Peschel C, Schwaiger M, Buck AK, Dechow T, Keller U

OncoTargets and Therapy 2014, 7:789-798

Published Date: 23 May 2014

Preparation and functional studies of hydroxyethyl chitosan nanoparticles loaded with anti-human death receptor 5 single-chain antibody

Yang J, Huang X, Luo F, Cheng X, Cheng L, Liu B, Chen L, Hu R, Shi C, Zhuang G, Yin P

OncoTargets and Therapy 2014, 7:779-787

Published Date: 21 May 2014

Manumycin induces apoptosis in prostate cancer cells

Li JG, She MR, Lu CY, Wei SS, Xia PF, Lu ZS, Peng Q

OncoTargets and Therapy 2014, 7:771-777

Published Date: 22 May 2014

Treating advanced non-small-cell lung cancer in Chinese patients: focus on icotinib

Liang JL, Ren XC, Lin Q

OncoTargets and Therapy 2014, 7:761-770

Published Date: 16 May 2014

Clinical potential of bevacizumab in the treatment of metastatic and locally advanced cervical cancer: current evidence

Jackson MW, Rusthoven CG, Fisher CM, Schefter TE

OncoTargets and Therapy 2014, 7:751-759

Published Date: 16 May 2014

Investigation and analysis of oncologists' knowledge of morphine usage in cancer pain treatment

Liu W, Xie S, Yue L, Liu J, Woo SML, Liu W, Miller AR, Zhang J, Huang L, Zhang L

OncoTargets and Therapy 2014, 7:729-737

Published Date: 13 May 2014

Clinical response to sunitinib as a multitargeted tyrosine-kinase inhibitor (TKI) in solid cancers: a review of clinical trials

Kim S, Ding W, Zhang L, Tian W, Chen S

OncoTargets and Therapy 2014, 7:719-728

Published Date: 12 May 2014

Considering the role of radiation therapy for gastrointestinal stromal tumor

Corbin KS, Kindler HL, Liauw SL

OncoTargets and Therapy 2014, 7:713-718

Published Date: 12 May 2014

IL-17A (-197G/A) and IL-17F (7488T/C) gene polymorphisms and cancer risk in Asian population: a meta-analysis

Dai W, Zhou Q, Tan X, Sun C

OncoTargets and Therapy 2014, 7:703-711

Published Date: 13 May 2014

Antitumor activity of sorafenib and imatinib in a patient with thymic carcinoma harboring c-KIT exon 13 missense mutation K642E

Catania C, Conforti F, Spitaleri G, Barberis M, Preda L, Noberasco C, Lazzari C, Toffalorio F, de Marinis F, Manzotti M, De Pas TM

OncoTargets and Therapy 2014, 7:697-702

Published Date: 8 May 2014

Quality of life assessment in advanced cancer patients treated at home, an inpatient unit, and a day care center

Leppert W, Majkowicz M, Forycka M, Mess E, Zdun-Ryzewska A

OncoTargets and Therapy 2014, 7:687-695

Published Date: 8 May 2014

Renal malignant solitary fibrous tumor with single lymph node involvement: report of unusual metastasis and review of the literature

Mearini E, Cochetti G, Barillaro F, Fatigoni S, Roila F

OncoTargets and Therapy 2014, 7:679-685

Published Date: 8 May 2014

Primary small-cell neuroendocrine carcinoma of the male breast: a rare case report with review of the literature

Jiang J, Wang GX, Lv L, Liu CG, Liang X, Zhao HD

OncoTargets and Therapy 2014, 7:663-666

Published Date: 6 May 2014

Stage-dependent prognostic impact of molecular signatures in clear cell renal cell carcinoma

Weber T, Meinhardt M, Zastrow S, Wienke A, Erdmann K, Hofmann J, Fuessel S, Wirth MP

OncoTargets and Therapy 2014, 7:645-654

Published Date: 2 May 2014

Involvement of c-KIT mutation in the development of gastrointestinal stromal tumors through proliferation promotion and apoptosis inhibition

Ma YY, Yu S, He XJ, Xu Y, Wu F, Xia YJ, Guo K, Wang HJ, Ye ZY, Zhang W, Tao HQ

OncoTargets and Therapy 2014, 7:637-643

Published Date: 2 May 2014

Two thymus-related autoimmune disorders: a case report and review of the literature

Mirtavoos-Mahyari H, Khosravi A, Esfahani-Monfared Z, Shadmehr MB

OncoTargets and Therapy 2014, 7:633-636

Published Date: 10 May 2014

Clinical utility of circulating tumor cell counting through CellSearch®: the dilemma of a concept suspended in Limbo

Raimondi C, Gradilone A, Naso G, Cortesi E, Gazzaniga P

OncoTargets and Therapy 2014, 7:619-625

Published Date: 17 April 2014

Neuropathic cancer pain: What we are dealing with? How to manage it?

Esin E, Yalcin S

OncoTargets and Therapy 2014, 7:599-618

Published Date: 17 April 2014

MiR-519d represses ovarian cancer cell proliferation and enhances cisplatin-mediated cytotoxicity in vitro by targeting XIAP

Pang Y, Mao H, Shen L, Zhao Z, Liu R, Liu P

OncoTargets and Therapy 2014, 7:587-597

Published Date: 23 April 2014

Microtubule-targeting agents in oncology and therapeutic potential in hepatocellular carcinoma

Loong HH, Yeo W

OncoTargets and Therapy 2014, 7:575-585

Published Date: 16 April 2014

Protein expression of programmed death 1 ligand 1 and ligand 2 independently predict poor prognosis in surgically resected lung adenocarcinoma

Zhang Y, Wang L, Li Y, Pan Y, Wang R, Hu H, Li H, Luo X, Ye T, Sun Y, Chen H

OncoTargets and Therapy 2014, 7:567-573

Published Date: 12 April 2014

PIK3CA mutations define favorable prognostic biomarkers in operable breast cancer: a systematic review and meta-analysis

Liu YR, Jiang YZ, Zuo WJ, Yu KD, Shao ZM

OncoTargets and Therapy 2014, 7:543-552

Published Date: 10 April 2014

Characterization of a fusion protein of RGD4C and the ß-lactamase variant for antibody-directed enzyme prodrug therapy

Zhou XL, Wang H, Shi PJ, Meng AM

OncoTargets and Therapy 2014, 7:535-541

Published Date: 10 April 2014

Micro-ribonucleic acid expression profiling and bioinformatic target gene analyses in laryngeal carcinoma

Lu ZM, Lin YF, Jiang L, Chen LS, Luo XN, Song XH, Chen SH, Zhang SY

OncoTargets and Therapy 2014, 7:525-533

Published Date: 5 April 2014

Primary concomitant EGFR T790M mutation predicted worse prognosis in non-small cell lung cancer patients

Li H, Hu H, Wang R, Pan Y, Wang L, Li Y, Zhang Y, Ye T, Zhang Y, Li B, Shen L, Sun Y, Chen H

OncoTargets and Therapy 2014, 7:513-524

Published Date: 3 April 2014

Role of capecitabine in treating metastatic colorectal cancer in Chinese patients

Wang F, Wang FH, Bai L, Xu RH

OncoTargets and Therapy 2014, 7:501-511

Published Date: 2 April 2014

Potential of antibody–drug conjugates and novel therapeutics in breast cancer management

Lianos GD, Vlachos K, Zoras O, Katsios C, Cho WC, Roukos DH

OncoTargets and Therapy 2014, 7:491-500

Published Date: 24 March 2014

Fractionated stereotactic radiosurgery with concurrent temozolomide chemotherapy for locally recurrent glioblastoma multiforme: a prospective cohort study

Greenspoon JN, Sharieff W, Hirte H, Overholt A, Devillers R, Gunnarsson T, Whitton A

OncoTargets and Therapy 2014, 7:485-490

Published Date: 24 March 2014

Retreatment with bevacizumab in patients with gynecologic malignancy is associated with clinical response and does not increase morbidity

Laskey RA, Richard SD, Smith AL, Lin JF, Beck TL, Lesnock JL, Kelley JL 3rd, Olawaiye AB, Sukumvanich P, Krivak TC

OncoTargets and Therapy 2014, 7:469-476

Published Date: 21 March 2014

Oncogene mutational profile in nasopharyngeal carcinoma

Zhang ZC, Fu S, Wang F, Wang HY, Zeng YX, Shao JY

OncoTargets and Therapy 2014, 7:457-467

Published Date: 20 March 2014

Clusterin: a key player in cancer chemoresistance and its inhibition

Koltai T

OncoTargets and Therapy 2014, 7:447-456

Published Date: 20 March 2014

Cancer cell-oriented migration of mesenchymal stem cells engineered with an anticancer gene (PTEN): an imaging demonstration

Yang ZS, Tang XJ, Guo XR, Zou DD, Sun XY, Feng JB, Luo J, Dai LJ, Warnock GL

OncoTargets and Therapy 2014, 7:441-446

Published Date: 17 March 2014

Gastrointestinal tract metastasis from tubulolobular carcinoma of the breast: a case report and review of the literature

Wang GX, Wang TJ, Jiang J, Zhou LY, Zhao HD

OncoTargets and Therapy 2014, 7:435-440

Published Date: 18 March 2014

A rehabilitation program for lung cancer patients during postthoracotomy chemotherapy

Hoffman AJ, Brintnall RA, von Eye A, Jones LW, Alderink G, Patzelt LH, Brown JK

OncoTargets and Therapy 2014, 7:415-423

Published Date: 10 March 2014

Clinical effectiveness, toxicity, and failure patterns of helical tomotherapy for postoperative oral cavity cancer patients

Hsieh CH, Shueng PW, Wang LY, Liao LJ, Lin YC, Kuo YS, Lo WC, Tseng CF, Tien HJ, Chou HL, Hsieh YP, Wu LJ, Chen YJ

OncoTargets and Therapy 2014, 7:405-414

Published Date: 10 March 2014

Development of anaplastic lymphoma kinase (ALK) inhibitors and molecular diagnosis in ALK rearrangement-positive lung cancer

Iwama E, Okamoto I, Harada T, Takayama K, Nakanishi Y

OncoTargets and Therapy 2014, 7:375-385

Published Date: 5 March 2014

Clinical impact of targeted therapies in patients with metastatic clear-cell renal cell carcinoma

Nerich V, Hugues M, Paillard MJ, Borowski L, Nai T, Stein U, Nguyen Tan Hon T, Montcuquet P, Maurina T, Mouillet G, Kleinclauss F, Pivot X, Limat S, Thiery-Vuillemin A

OncoTargets and Therapy 2014, 7:365-374

Published Date: 27 February 2014

Cyclooxygenase-2 inhibitor is a robust enhancer of anticancer agents against hepatocellular carcinoma multicellular spheroids

Cui J, Guo YH, Zhang HY, Jiang LL, Ma JQ, Wang WJ, Wang MC, Yang CC, Nan KJ, Song LP

OncoTargets and Therapy 2014, 7:353-363

Published Date: 24 February 2014

ABCC4 is required for cell proliferation and tumorigenesis in non-small cell lung cancer

Zhao X, Guo Y, Yue W, Zhang L, Gu M, Wang Y

OncoTargets and Therapy 2014, 7:343-351

Published Date: 21 February 2014

Isotype-specific inhibition of the phosphatidylinositol-3-kinase pathway in hematologic malignancies

Castillo JJ, Iyengar M, Kuritzky B, Bishop KD

OncoTargets and Therapy 2014, 7:333-342

Published Date: 21 February 2014

miR-7 inhibits colorectal cancer cell proliferation and induces apoptosis by targeting XRCC2

Xu K, Chen Z, Qin C, Song X

OncoTargets and Therapy 2014, 7:325-332

Published Date: 20 February 2014

Recent advances in the ARID family: focusing on roles in human cancer

Lin C, Song W, Bi XY, Zhao JJ, Huang Z, Li ZY, Zhou JG, Cai JQ, Zhao H

OncoTargets and Therapy 2014, 7:315-324

Published Date: 18 February 2014

Axitinib for preoperative downstaging of renal cell carcinoma with sarcomatoid differentiation and direct invasion of the duodenum and inferior vena cava: a case report

Yuki H, Kamai T, Kubota K, Abe H, Nishihara D, Mizuno T, Masuda A, Betsunoh H, Yashi M, Fukabori Y, Yoshida KI

OncoTargets and Therapy 2014, 7:289-295

Published Date: 15 February 2014

Nickel nanoparticle-induced dose-dependent cyto-genotoxicity in human breast carcinoma MCF-7 cells

Ahamed M, Alhadlaq HA

OncoTargets and Therapy 2014, 7:269-280

Published Date: 14 February 2014

Targeted treatment of head and neck squamous-cell carcinoma: potential of lapatinib

Gandhi MD, Agulnik M

OncoTargets and Therapy 2014, 7:245-251

Published Date: 13 February 2014

Treating malignant glioma in Chinese patients: update on temozolomide

Chang L, Su J, Jia X, Ren H

OncoTargets and Therapy 2014, 7:235-244

Published Date: 12 February 2014

Mechanism of action and clinical activity of tasquinimod in castrate-resistant prostate cancer

Gupta N, Al Ustwani O, Shen L, Pili R

OncoTargets and Therapy 2014, 7:223-234

Published Date: 12 February 2014

Midazolam induces apoptosis in MA-10 mouse Leydig tumor cells through caspase activation and the involvement of MAPK signaling pathway

So EC, Lin YX, Tseng CH, Pan BS, Cheng KS, Wong KL, Hao LJ, Wang YK, Huang BM

OncoTargets and Therapy 2014, 7:211-221

Published Date: 13 February 2014

Ipilimumab in the treatment of metastatic melanoma: management of adverse events

Della Vittoria Scarpati G, Fusciello C, Perri F, Sabbatino F, Ferrone S, Carlomagno C, Pepe S

OncoTargets and Therapy 2014, 7:203-209

Published Date: 19 February 2014

Dichloroacetate modulates cytokines toward T helper 1 function via induction of the interleukin-12–interferon-γ pathway

Badr MM, Qinna NA, Qadan F, Matalka KZ

OncoTargets and Therapy 2014, 7:193-201

Published Date: 7 February 2014

Nab-paclitaxel: potential for the treatment of advanced pancreatic cancer

Al-Hajeili M, Azmi AS, Choi M

OncoTargets and Therapy 2014, 7:187-192

Published Date: 4 February 2014

Omacetaxine mepesuccinate in the treatment of intractable chronic myeloid leukemia

Chen Y, Li S

OncoTargets and Therapy 2014, 7:177-186

Published Date: 31 January 2014

Effective use of everolimus as salvage chemotherapy for ovarian clear cell carcinoma: a case report

Takatori E, Shoji T, Miura Y, Takada A, Takeuchi S, Sugiyama T

OncoTargets and Therapy 2014, 7:165-169

Published Date: 29 January 2014

Combined overexpression of HIVEP3 and SOX9 predicts unfavorable biochemical recurrence- free survival in patients with prostate cancer

Qin GQ, He HC, Han ZD, Liang YX, Yang SB, Huang YQ, Zhou L, Fu H, Li JX, Jiang FN, Zhong WD

OncoTargets and Therapy 2014, 7:137-146

Published Date: 24 January 2014

Therapeutic targeting of Neu1 sialidase with oseltamivir phosphate (Tamiflu®) disables cancer cell survival in human pancreatic cancer with acquired chemoresistance

O’Shea LK, Abdulkhalek S, Allison S, Neufeld RJ, Szewczuk MR

OncoTargets and Therapy 2014, 7:117-134

Published Date: 16 January 2014

Clear cell carcinoma of the uterine cervix: clinical characteristics and feasibility of fertility-preserving treatment

Jiang X, Jin Y, Li Y, Huang HF, Wu M, Shen K, Pan LY

OncoTargets and Therapy 2014, 7:111-116

Published Date: 9 January 2014

Effect of onion flavonoids on colorectal cancer with hyperlipidemia: an in vivo study

He Y, Jin H, Gong W, Zhang C, Zhou A

OncoTargets and Therapy 2014, 7:101-110

Published Date: 8 January 2014

Comparison of concurrent chemoradiotherapy followed by radical surgery and high-dose-rate intracavitary brachytherapy: a retrospective study of 240 patients with FIGO stage IIB cervical carcinoma

Wang N, Li WW, Li JP, Liu JY, Zhou YC, Zhang Y, Hu J, Huang YH, Chen Y, Wei LC, Shi M

OncoTargets and Therapy 2014, 7:91-100

Published Date: 6 January 2014

The long-term survival of a thymic carcinoma patient treated with S-1: a case report and literature review

Tanaka H, Morimoto T, Taima K, Tanaka Y, Nakamura K, Hayashi A, Kurose A, Okumura K, Takanashi S

OncoTargets and Therapy 2014, 7:87-90

Published Date: 27 December 2013

High expression of Sonic Hedgehog signaling pathway genes indicates a risk of recurrence of breast carcinoma

Jeng KS, Sheen IS, Jeng WJ, Yu MC, Hsiau HI, Chang FY

OncoTargets and Therapy 2014, 7:79-86

Published Date: 27 December 2013

Uncovering the role of p53 splice variants in human malignancy: a clinical perspective

Surget S, Khoury MP, Bourdon JC

OncoTargets and Therapy 2014, 7:57-68

Published Date: 19 December 2013

Targeted therapy for Hodgkin lymphoma and systemic anaplastic large cell lymphoma: focus on brentuximab vedotin

Chen X, Soma LA, Fromm JR

OncoTargets and Therapy 2014, 7:45-56

Published Date: 19 December 2013

Emerging concepts in pancreatic cancer medicine: targeting the tumor stroma

Neesse A, Krug S, Gress TM, Tuveson DA, Michl P

OncoTargets and Therapy 2014, 7:33-43

Published Date: 18 December 2013

hnRNP C1/C2 and Pur-beta proteins mediate induction of senescence by oligonucleotides homologous to the telomere overhang

Mulnix RE, Pitman RT, Retzer A, Bertram C, Arasi K, Crees Z, Girard J, Uppada SB, Stone AL, Puri N

OncoTargets and Therapy 2014, 7:23-32

Published Date: 18 December 2013

Management of cytopenias in patients with myelofibrosis treated with ruxolitinib and effect of dose modifications on efficacy outcomes

Verstovsek S, Gotlib J, Gupta V, Atallah E, Mascarenhas J, Quintas-Cardama A, Sun W, Sarlis NJ, Sandor V, Levy RS, Kantarjian HM, Mesa RA

OncoTargets and Therapy 2014, 7:13-21

Published Date: 17 December 2013

The -159C/T polymorphism in the CD14 gene and cancer risk: a meta-analysis

Zhou W, Jia L, Guo S, Hu Q, Shen Y, Li N

OncoTargets and Therapy 2014, 7:5-12

Published Date: 10 December 2013

Primary malignant fibrous histiocytoma of the renal pelvis: a 78-month follow-up case report

Chen YB, Rao D, Zhu H, Yu H, Yang SK

OncoTargets and Therapy 2014, 7:1-3

Published Date: 17 December 2013